4 recruiting, 2 completed, 2 not yet recruiting. 3 Not applicable, 3 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 3 | Recruiting 2, Completed 1 |
| Phase 2 | 2 | Recruiting 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow ESRD (End-Stage Renal Disease): new trials by email Literature Review of ESRD (End-Stage Renal Disease) trials Research Report on ESRD (End-Stage Renal Disease)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD GGTA1 KO Thymokidney - ESRD (End-Stage Renal Disease), Kidney Transplantation | Phase 1 / Phase 2 | Recruiting | United Therapeutics | 50 | 2026-11-01 | 2026-09-09 |
| Continuous Glucose Monitoring and Clinical Outcomes in Diabetes on Peritoneal Dialysis Continuous glucose monitoring system - Continuous Glucose Monitoring, ESRD (End-Stage Renal Disease) | Not yet recruiting | Elaine Chow | 100 | 2026-08-31 | 2026-08-27 | |
| Efficacy of pHA130 Hemoadsorption on Protein-Bound Uremic Toxins and Quality of Life in Kidney Failure pHA130 Hemoadsorption Cartridge, High-flux Hemodialyzer - ESRD (End-Stage Renal Disease), Maintenance Hemodialysis | Not applicable | Recruiting | China-Japan Friendship Hospital | 100 | 2026-06-01 | 2026-06-25 |
| Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD 10 GE Xenokidney - ESRD (End-Stage Renal Disease), Kidney Transplantation | Phase 1 / Phase 2 | Recruiting | United Therapeutics | 50 | 2025-10-29 | 2026-03-27 |
| The Effects of a Dialysis-Specific Formula Rich in Branched-Chain Amino Acids, Omega-3, and Dietary Fiber on Nutritional Status BOSCOGEN 18% Protein ONS: Energy 480 kcal, Protein 21.6 g, BCAA 6000 mg, Omega-3 fatty acid 1.8 g, fiber 5 g, Fresubin dialysis ONS (200 ml): Energy 300 kcal, Protein 20 g, BCAA - mg, Omega-3 fatty acid - g, fiber 0.2 g - ESRD (End-Stage Renal Disease), Dialysis | Not applicable | Not yet recruiting | Buddhist Tzu Chi General Hospital | 100 | 2025-07-01 | 2025-07-11 |
| A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China AP301, AP301 Low Dose - Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis | Phase 3 | Recruiting | Alebund Pharmaceuticals | 264 | 2025-06-13 | 2026-01-29 |
| Evaluation of the Application of Intelligent Applications in Patients Undergoing Peritoneal Dialysis Conventional Follow-up, Weiyin Health Smart Application - Kidney Failure Chronic, ESRD (End-Stage Renal Disease) | Not applicable | Completed | The Third Xiangya Hospital of Central South University | 223 | 2024-07-01 | 2026-05-28 |
| A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment BMS-986177 - Thrombosis, Factor XI | Phase 1 | Completed | Bristol-Myers Squibb | 6 | 2016-11-01 | 2017-07-27 |
Renal Insufficiency, Chronic (8) · Kidney Failure, Chronic (2) · Diabetes Mellitus (1) · Hyperphosphatemia (1) · Protein-Energy Malnutrition (1) · Renal Insufficiency (1) · Thrombosis (1)
Chronic Disease (8) · Disease Attributes (8) · Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Kidney Diseases (8) · Male Urogenital Diseases (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Urogenital Diseases (8) · Urologic Diseases (8) · Renal Insufficiency (7) · Nutritional and Metabolic Diseases (3) · Metabolic Diseases (2) · Cardiovascular Diseases (1) · Deficiency Diseases (1)
Continuous Glucose Monitoring (1) · Dietary Fiber (1) · Fatty Acids, Omega-3 (1) · Proteins (1) · milvexian (1)
United Therapeutics (2) · Alebund Pharmaceuticals (1) · Bristol-Myers Squibb (1) · Buddhist Tzu Chi General Hospital (1) · China-Japan Friendship Hospital (1) · Elaine Chow (1) · The Third Xiangya Hospital of Central South University (1)
United States (4) · China (3) · Hong Kong (1)
Elaine Chow (1) · Wenge Li, MD (1)